NCT01600807
OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas treatment 1 / 2 withdrawn NCT02143219
Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer treatment 2 completed NCT01174121
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer No drug interventions treatment 2 recruiting NCT04409002
Niraparib + Dostarlimab + RT in Pancreatic Cancer No drug interventions treatment 2 completed NCT04820179
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer No drug interventions treatment 2 recruiting NCT04002479
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT01839487
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer treatment 2 completed NCT06078787
Olaparib in PALB2 Advanced Pancreatic Cancer treatment 2 recruiting NCT00652054
Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer No drug interventions treatment 2 completed NCT01744353
BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study treatment 1 completed NCT03261947
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors treatment 2 completed NCT00761345
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer treatment 1 completed NCT05360745
Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer. No drug interventions supportive_care Not Available withdrawn NCT02866383
Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients treatment 2 completed NCT00986661
A Study to Assess PV-10 Chemoablation of Cancer of the Liver treatment 1 active_not_recruiting NCT01510561
A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies. treatment 1 withdrawn NCT05042128
The ASCEND Study: Gemcitabine and Nab-Paclitaxel With CEND-1/LSTA1 or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 active_not_recruiting NCT00326911
Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer treatment 2 terminated NCT01210911
Metformin Combined With Chemotherapy for Pancreatic Cancer treatment 2 completed NCT02205788
Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas No drug interventions Not Available Not Available withdrawn NCT06538207
An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer treatment 1 active_not_recruiting NCT05929885
Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients No drug interventions treatment 2 recruiting NCT03602885
EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options No drug interventions health_services_research Not Available completed NCT02352337
First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem treatment 2 completed NCT03666832
Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel treatment 1 / 2 unknown_status NCT02691052
Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program No drug interventions Not Available Not Available completed NCT01040000
QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer treatment 1 / 2 completed NCT01417000
Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer treatment 2 completed NCT02983500
Patient Reported Outcomes Registry in Patient With Cancer Cachexia No drug interventions Not Available Not Available completed NCT02707159
Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients diagnostic 2 completed NCT05138159
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen treatment 2 unknown_status NCT03821870
Predictive Value of Analysing Tissue From Patients With Metastatic Pancreatic Cancer for Drug Sensitivity No drug interventions Not Available Not Available completed NCT04844970
Anamorelin Study for Advanced Pancreatic Cancer supportive_care 2 recruiting NCT02967770
Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic Cancer No drug interventions treatment 2 withdrawn NCT05143970
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04150042
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells treatment 1 recruiting NCT01130142
A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT02028806
mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT01494506
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer treatment 3 completed NCT00844649
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas treatment 3 completed NCT05442749
Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer treatment 2 recruiting NCT02555813
Treatment of Pancreatic Cancer With Abraxane Not Available Not Available completed NCT02109341
Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT02340117
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer treatment 2 unknown_status NCT01964534
Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer treatment 2 unknown_status NCT01934634
Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer treatment 1 unknown_status NCT01571024
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer treatment 1 completed NCT05714124
Liver Embolization Approaches for Tumor Management No drug interventions Not Available Not Available recruiting NCT05586516
A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer treatment 1 / 2 recruiting NCT03487016
First-line Therapy in Metastatic PDAC treatment 2 unknown_status NCT00922896
Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer treatment 2 completed NCT06018896
Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer treatment 2 recruiting NCT02697058
Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer treatment 2 completed NCT03468335
2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy treatment 3 active_not_recruiting NCT02404363
Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy treatment 3 terminated NCT05417386
FOLFIRINOX + NIS793 in Pancreatic Cancer treatment 1 terminated NCT00398086
Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT03168139
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer treatment 1 / 2 completed NCT00447122
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer treatment 1 terminated NCT02282722
Improving Informed Consent for Palliative Chemotherapy No drug interventions other Not Available completed NCT00954525
Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer treatment 1 completed NCT05634525
Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients treatment 1 recruiting NCT02362048
ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT01523457
Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer No drug interventions treatment 2 completed NCT00709826
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer treatment 2 completed NCT04212026
Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer. treatment 2 terminated NCT05869474
Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma No drug interventions treatment Not Available recruiting NCT00919282
Gemcitabine (GFF) in Patients With Pancreatic Cancer treatment 2 completed NCT01796782
QYHJ Granules Versus Xeloda in Metastatic Pancreatic Cancer treatment 2 unknown_status NCT06532331
A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer treatment 1 recruiting NCT00837031
Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas treatment 2 completed NCT02734160
A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer treatment 1 completed NCT03929094
Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer treatment 2 unknown_status NCT04361162
Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer treatment 2 active_not_recruiting NCT05642962
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) treatment 1 / 2 recruiting NCT00245362
A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer No drug interventions treatment 2 completed NCT03331562
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer treatment 2 completed NCT01303029
Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT03435289
A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer treatment 1 unknown_status NCT04498689
Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer treatment 2 unknown_status NCT05940844
Study of OB-002 in Patients With Refractory Metastatic Cancer No drug interventions treatment 1 not_yet_recruiting NCT03563144
QUILT-3.088: NANT Pancreatic Cancer Vaccine treatment 2 withdrawn NCT00744640
Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma treatment 1 / 2 completed NCT04718701
Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer treatment 2 unknown_status NCT06059001
Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC treatment 1 recruiting NCT04229004
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer treatment 3 active_not_recruiting NCT06106568
An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions No drug interventions Not Available Not Available active_not_recruiting NCT03086369
A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT01946646
Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer No drug interventions treatment 1 terminated NCT02921646
Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas Cancer No drug interventions other Not Available terminated NCT06168812
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer treatment 2 recruiting NCT01956812
Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer treatment 3 terminated NCT03785210
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers treatment 2 completed NCT04177810
Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer treatment 2 completed NCT01028495
A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer treatment 2 completed NCT00868114
Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer No drug interventions treatment 2 terminated NCT04769414
Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) treatment 2 completed NCT04300114
A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy treatment 3 terminated NCT04133155
Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer Not Available Not Available completed NCT05827055
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer treatment 2 recruiting NCT05251038
Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer treatment 1 / 2 withdrawn NCT01621243
M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer treatment 1 / 2 terminated NCT03502343
Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer treatment 2 unknown_status NCT03627390
BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer treatment 2 completed NCT02080221
BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial treatment 2 completed NCT04753879
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. treatment 2 recruiting NCT00439179
A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema No drug interventions treatment 1 completed NCT03908333
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer treatment 1 / 2 withdrawn NCT00996333
Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) treatment 2 completed NCT01764477
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma treatment 1 completed NCT03693677
First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI treatment 2 active_not_recruiting NCT01231347
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas treatment 3 completed NCT04665947
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer treatment 0 recruiting NCT04672005
Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer treatment 2 active_not_recruiting NCT03620461
Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma. Not Available Not Available completed NCT01509911
A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment treatment 2 unknown_status NCT02570711
Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer treatment 2 terminated NCT06361888
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer No drug interventions treatment 2 / 3 recruiting NCT05363007
Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma No drug interventions treatment 2 recruiting NCT01088815
Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas No drug interventions treatment 2 completed NCT05737615
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 No drug interventions diagnostic 1 recruiting NCT01461915
Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients No drug interventions treatment 2 terminated NCT00726037
A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer No drug interventions treatment 2 terminated NCT06533332
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05360732
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients No drug interventions treatment 2 recruiting NCT00630552
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT03376659
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma No drug interventions treatment 1 / 2 terminated NCT01524575
Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1 No drug interventions treatment 2 withdrawn NCT05927142
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy No drug interventions other 1 / 2 recruiting NCT00786006
Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer No drug interventions treatment 2 completed NCT00383149
A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer No drug interventions treatment 2 completed NCT05346536
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) No drug interventions other Not Available unknown_status NCT04112836
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT04605913
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC No drug interventions treatment 1 / 2 recruiting NCT04222413
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05650918
MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial) No drug interventions other 1 completed NCT01608841
The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib No drug interventions treatment 2 unknown_status NCT04901741
Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer No drug interventions treatment 2 not_yet_recruiting NCT02975141
Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer No drug interventions other 1 unknown_status NCT04589234
Saltikva for Metastatic Pancreatic Cancer No drug interventions treatment 2 active_not_recruiting NCT02184663
Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer No drug interventions basic_science Not Available active_not_recruiting NCT03816163
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer No drug interventions treatment 2 active_not_recruiting NCT01077986
Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT04327986
Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer No drug interventions treatment 1 / 2 terminated NCT03697239
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 withdrawn NCT04612530
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer No drug interventions treatment 1 recruiting NCT05766748
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 recruiting NCT06454448
Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 recruiting NCT03415126
A Study of ASN007 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT06199466
A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer No drug interventions treatment 1 recruiting NCT01489865
ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 unknown_status NCT03281382
Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer No drug interventions treatment 1 completed NCT03250273
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma No drug interventions treatment 2 completed NCT03986294
Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer No drug interventions treatment 2 unknown_status NCT01272791
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer No drug interventions treatment 2 completed NCT04789980
Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY No drug interventions Not Available Not Available recruiting NCT04101929
Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen No drug interventions treatment 2 unknown_status NCT03682289
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors No drug interventions treatment 2 recruiting NCT03721744
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer No drug interventions treatment 2 / 3 recruiting NCT06532344
An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer No drug interventions treatment 1 active_not_recruiting NCT02863367
A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer No drug interventions treatment 2 unknown_status NCT02827201
FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine No drug interventions treatment 2 completed NCT05065801
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients No drug interventions treatment 2 recruiting NCT03446872
Post Marketing Surveillance Study for ONIVYDE® in South Korea No drug interventions Not Available Not Available completed NCT01410968
A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma No drug interventions treatment 1 completed NCT00222469
Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer No drug interventions prevention 2 completed NCT02564146
First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine No drug interventions treatment 2 completed NCT02781012
Project Survival-Prospective Biomarker Discovery No drug interventions Not Available Not Available unknown_status NCT06353581
Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX No drug interventions prevention 2 active_not_recruiting NCT02077881
Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT04790695
Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab No drug interventions treatment 2 completed NCT05659914
Olaparib and Durvalumab (MEDI4736) in Patients With Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations No drug interventions treatment 2 recruiting NCT05380414
Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients No drug interventions screening Not Available recruiting NCT05988814
Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy No drug interventions treatment 2 recruiting NCT03189914
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT06483555
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel No drug interventions treatment 1 / 2 not_yet_recruiting NCT03714555
Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine No drug interventions treatment 2 terminated NCT06017323
Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal Adenocarcinoma No drug interventions treatment 1 withdrawn NCT06469138
A Phase 1 Study to Investigate 14C-bemcentinib Following Single Oral Administration in Healthy Male Subjects No drug interventions treatment 1 completed NCT03797443
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer No drug interventions treatment 1 / 2 withdrawn NCT05657743
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT02959151
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy No drug interventions treatment 1 / 2 unknown_status NCT04467593
Safety Study of Whole Body Hyperthermia for Advanced Cancer No drug interventions treatment Not Available recruiting NCT06076837
The Seven Trial: Exploiting the Unfolded Protein Response treatment 1 not_yet_recruiting NCT03412799
Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer treatment 1 completed NCT06155136
RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan No drug interventions Not Available Not Available active_not_recruiting NCT05047991
Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma treatment 2 not_yet_recruiting NCT03984214
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer treatment 3 active_not_recruiting NCT03504423
Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas treatment 3 completed NCT04667403
Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer No drug interventions supportive_care Not Available unknown_status NCT05254171
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer No drug interventions treatment 2 / 3 recruiting NCT04469556
Pancreatic Adenocarcinoma Signature Stratification for Treatment No drug interventions treatment 2 active_not_recruiting NCT04674956
A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer No drug interventions treatment 3 recruiting NCT04338763
RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer No drug interventions treatment 1 recruiting NCT06030622
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer No drug interventions other 1 / 2 recruiting NCT04799431
Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer No drug interventions treatment 1 withdrawn NCT04116073
INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer No drug interventions treatment 2 recruiting NCT01652976
Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma No drug interventions treatment 2 completed NCT04852367
PanDox: Targeted Doxorubicin in Pancreatic Tumours No drug interventions basic_science 1 withdrawn NCT04721301
Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial No drug interventions treatment 1 completed NCT01843725
Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers No drug interventions treatment 1 completed NCT04907643
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes No drug interventions supportive_care Not Available recruiting NCT04835402
Electroporation Potentiated Immunotherapy in Cancer treatment 2 active_not_recruiting NCT02109445
Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies treatment 2 terminated NCT04897854
Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer No drug interventions treatment 3 unknown_status NCT01586611
A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer treatment 3 unknown_status NCT03126435
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX No drug interventions treatment 3 completed NCT02885727
Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598) No drug interventions treatment 2 withdrawn